Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Cytochrome b 5 impacts on cytochrome P450-mediated metabolism of benzo[a]pyrene and its DNA adduct formation: studies in hepatic cytochrome b 5 /P450 reductase null (HBRN) mice

L. Reed, I. Mrizova, F. Barta, R. Indra, M. Moserova, K. Kopka, HH. Schmeiser, CR. Wolf, CJ. Henderson, M. Stiborova, DH. Phillips, VM. Arlt,

. 2018 ; 92 (4) : 1625-1638. [pub] 20180124

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19028602

Grantová podpora
101126/B/13/Z Wellcome Trust - United Kingdom
101126/Z/13/Z Wellcome Trust - United Kingdom
17-12816S Grant Agency for Czech Republic
10822 Cancer Research UK - United Kingdom
C4639/A10822 Cancer Research UK - United Kingdom
C313/A14329 Cancer Research UK - United Kingdom
NE/L006782/1 Natural Environmental Research Council
1524896 Medical Research Council - United Kingdom

E-zdroje Online Plný text

NLK ProQuest Central od 2002-01-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2000-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2002-01-01 do Před 1 rokem
Public Health Database (ProQuest) od 2002-01-01 do Před 1 rokem

Benzo[a]pyrene (BaP) is an environmental pollutant that, based on evidence largely from in vitro studies, exerts its genotoxic effects after metabolic activation by cytochrome P450s. In the present study, Hepatic Reductase Null (HRN) and Hepatic Cytochrome b 5 /P450 Reductase Null (HBRN) mice have been used to study the role of P450s in the metabolic activation of BaP in vivo. In HRN mice, cytochrome P450 oxidoreductase (POR), the electron donor to P450, is deleted specifically in hepatocytes. In HBRN mice the microsomal haemoprotein cytochrome b 5 , which can also act as an electron donor from cytochrome b 5 reductase to P450s, is also deleted in the liver. Wild-type (WT), HRN and HBRN mice were treated by i.p. injection with 125 mg/kg body weight BaP for 24 h. Hepatic microsomal fractions were isolated from BaP-treated and untreated mice. In vitro incubations carried out with BaP-pretreated microsomal fractions, BaP and DNA resulted in significantly higher BaP-DNA adduct formation with WT microsomal fractions compared to those from HRN or HBRN mice. Adduct formation (i.e. 10-(deoxyguanosin-N2-yl)-7,8,9-trihydroxy-7,8,9,10-tetrahydro-BaP [dG-N2-BPDE]) correlated with observed CYP1A activity and metabolite formation (i.e. BaP-7,8-dihydrodiol) when NADPH or NADH was used as enzymatic cofactors. BaP-DNA adduct levels (i.e. dG-N2-BPDE) in vivo were significantly higher (~ sevenfold) in liver of HRN mice than WT mice while no significant difference in adduct formation was observed in liver between HBRN and WT mice. Our results demonstrate that POR and cytochrome b 5 both modulate P450-mediated activation of BaP in vitro. However, hepatic P450 enzymes in vivo appear to be more important for BaP detoxification than its activation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028602
003      
CZ-PrNML
005      
20250423153048.0
007      
ta
008      
190813s2018 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00204-018-2162-7 $2 doi
035    __
$a (PubMed)29368147
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Reed, Lindsay $u Department of Analytical, Environmental and Forensic Sciences, MRC-PHE Centre for Environment and Health, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK.
245    10
$a Cytochrome b 5 impacts on cytochrome P450-mediated metabolism of benzo[a]pyrene and its DNA adduct formation: studies in hepatic cytochrome b 5 /P450 reductase null (HBRN) mice / $c L. Reed, I. Mrizova, F. Barta, R. Indra, M. Moserova, K. Kopka, HH. Schmeiser, CR. Wolf, CJ. Henderson, M. Stiborova, DH. Phillips, VM. Arlt,
520    9_
$a Benzo[a]pyrene (BaP) is an environmental pollutant that, based on evidence largely from in vitro studies, exerts its genotoxic effects after metabolic activation by cytochrome P450s. In the present study, Hepatic Reductase Null (HRN) and Hepatic Cytochrome b 5 /P450 Reductase Null (HBRN) mice have been used to study the role of P450s in the metabolic activation of BaP in vivo. In HRN mice, cytochrome P450 oxidoreductase (POR), the electron donor to P450, is deleted specifically in hepatocytes. In HBRN mice the microsomal haemoprotein cytochrome b 5 , which can also act as an electron donor from cytochrome b 5 reductase to P450s, is also deleted in the liver. Wild-type (WT), HRN and HBRN mice were treated by i.p. injection with 125 mg/kg body weight BaP for 24 h. Hepatic microsomal fractions were isolated from BaP-treated and untreated mice. In vitro incubations carried out with BaP-pretreated microsomal fractions, BaP and DNA resulted in significantly higher BaP-DNA adduct formation with WT microsomal fractions compared to those from HRN or HBRN mice. Adduct formation (i.e. 10-(deoxyguanosin-N2-yl)-7,8,9-trihydroxy-7,8,9,10-tetrahydro-BaP [dG-N2-BPDE]) correlated with observed CYP1A activity and metabolite formation (i.e. BaP-7,8-dihydrodiol) when NADPH or NADH was used as enzymatic cofactors. BaP-DNA adduct levels (i.e. dG-N2-BPDE) in vivo were significantly higher (~ sevenfold) in liver of HRN mice than WT mice while no significant difference in adduct formation was observed in liver between HBRN and WT mice. Our results demonstrate that POR and cytochrome b 5 both modulate P450-mediated activation of BaP in vitro. However, hepatic P450 enzymes in vivo appear to be more important for BaP detoxification than its activation.
650    _2
$a zvířata $7 D000818
650    _2
$a benzopyren $x metabolismus $7 D001564
650    _2
$a cytochrom-B(5)-reduktasa $x metabolismus $7 D042966
650    _2
$a adukty DNA $x metabolismus $7 D018736
650    _2
$a hepatocyty $x enzymologie $7 D022781
650    _2
$a myši $7 D051379
650    _2
$a myši knockoutované $7 D018345
650    _2
$a jaterní mikrozomy $x enzymologie $7 D008862
650    _2
$a NADPH-cytochrom c-reduktasa $x metabolismus $7 D009251
655    _2
$a časopisecké články $7 D016428
700    1_
$a Mrizova, Iveta $u Department of Biochemistry, Faculty of Science, Charles University, Albertov 2030, 128 40, Prague 2, Czech Republic.
700    1_
$a Bárta, František $u Department of Biochemistry, Faculty of Science, Charles University, Albertov 2030, 128 40, Prague 2, Czech Republic. $7 xx0331419
700    1_
$a Indra, Radek $u Department of Biochemistry, Faculty of Science, Charles University, Albertov 2030, 128 40, Prague 2, Czech Republic.
700    1_
$a Moserova, Michaela $u Department of Biochemistry, Faculty of Science, Charles University, Albertov 2030, 128 40, Prague 2, Czech Republic.
700    1_
$a Kopka, Klaus $u Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
700    1_
$a Schmeiser, Heinz H $u Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
700    1_
$a Wolf, C Roland $u Division of Cancer Research, Jacqui Wood Cancer Centre, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, DD1 9SY, UK.
700    1_
$a Henderson, Colin J $u Division of Cancer Research, Jacqui Wood Cancer Centre, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, DD1 9SY, UK.
700    1_
$a Stiborova, Marie $u Department of Biochemistry, Faculty of Science, Charles University, Albertov 2030, 128 40, Prague 2, Czech Republic.
700    1_
$a Phillips, David H $u Department of Analytical, Environmental and Forensic Sciences, MRC-PHE Centre for Environment and Health, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK.
700    1_
$a Arlt, Volker M $u Department of Analytical, Environmental and Forensic Sciences, MRC-PHE Centre for Environment and Health, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK. volker.arlt@kcl.ac.uk.
773    0_
$w MED00009265 $t Archives of toxicology $x 1432-0738 $g Roč. 92, č. 4 (2018), s. 1625-1638
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29368147 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20250423153048 $b ABA008
999    __
$a ok $b bmc $g 1433751 $s 1067062
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 92 $c 4 $d 1625-1638 $e 20180124 $i 1432-0738 $m Archives of toxicology $n Arch Toxicol $x MED00009265
GRA    __
$a 101126/B/13/Z $p Wellcome Trust $2 United Kingdom
GRA    __
$a 101126/Z/13/Z $p Wellcome Trust $2 United Kingdom
GRA    __
$a 17-12816S $p Grant Agency for Czech Republic
GRA    __
$a 10822 $p Cancer Research UK $2 United Kingdom
GRA    __
$a C4639/A10822 $p Cancer Research UK $2 United Kingdom
GRA    __
$a C313/A14329 $p Cancer Research UK $2 United Kingdom
GRA    __
$a NE/L006782/1 $p Natural Environmental Research Council
GRA    __
$a 1524896 $p Medical Research Council $2 United Kingdom
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...